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LETTERS TO THE EDITOR
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1Regarding “Remote and local ischemic
preconditioning equivalently protects rat skeletal
muscle mitochondrial function during experimental
aortic cross-clamping”
Mansour et al1 showed that local and remote ischemic precon-
ditioning (LIPC and RIPC) protect skeletal muscle against isch-
emia reperfusion-inducedmitochondrial dysfunction during aortic
cross-clamping. Based on these results, the authors advocate a
broader use of RIPC in the setting of vascular surgery. Recently, we
performed a systematic review and meta-analysis of animal studies
investigating the effects of ischemic preconditioning on ischemia-
reperfusion injury (IRI) of the kidney.2 Our analysis showed that
LIPC and RIPC are equally effective in the protection against renal
IRI and therefore support the conclusion by Mansour et al1 that
LIPC and RIPC equivalently protects against skeletal muscle IRI.
To date, no studies (animal or human) have investigated the
effect of aging, medication, and comorbidities such as diabetes,
hypertension, or obesity on RIPC in skeletal muscle or renal IRI.
For the heart, it has been shown that aging, medication, and
comorbidities influence ischemic preconditioning efficacy.3 In the
study by Mansour et al,1 and also in the majority of other animal
studies investigating the effects of ischemic preconditioning,
healthy young adult animals have been used. Therefore, the ques-
tion arises whether the efficacy of RIPC holds for patients with
cardiovascular (co)-morbidity. In our view, testing of suboptimal
RIPC protocols in large clinical trials could unnecessarily delay
implementation into routine clinical practice, due to marginal or
negative results.
Interestingly, our meta-analysis also revealed that the “late
window of protection” (RIPC 24 hours before index ischemia)
was more effective as compared to the “early window of protec-
tion” (RIPC 24 hours). Therefore, activation of both (early and
late) windows of protection by RIPCmight also result in improved
protection against IRI of human skeletal muscle and other target
organs. Because patients undergoing major vascular surgery are
exposed to a significant risk of myocardial and renal IRI, we believe
that the RIPC protocol should be optimized for different target
organs in vascular patients. Almost all clinical trials currently reg-
istered at http://Clinicaltrials.gov investigating the effects of
RIPC use the early window of protection. To our knowledge, data
on the efficacy of combined activation of the early and late window
in humans are lacking. Therefore, we believe that further (pre)clin-
ical research is required to optimize the RIPC protocol in cardio-
vascular patients before a broader implementation in vascular
surgery.
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We appreciate Dr Menting and colleague’s comments and
greement on the fact that local and remote ischemic precondi-
ioning (IPC and rIPC) proved equivalent protection on skeletal
uscle and kidneys during ischemia-reperfusion. A similar protec-
ion was also observed on other target organs.1-3 Further, unlike
ostconditioning,4 IPC and rIPC have not been demonstrated to
e deleterious on skeletal muscle.
Nevertheless, whether efficacy of IPC and rIPC holds true in
ascular patients characterized by comorbidities remains a signifi-
ant issue because conditioning-related cardioprotective proper-
ies appeared reduced in presence of diabetes, hypercholesterol-
mia, or older age. Additionally, specific organ sensitivity to
schemia-reperfusion, oxidative stress, and inflammation might
lso be key limiting factors of IPC and rIPC protective effects.
hus, a protocol algorithm might well protect one organ and not
he others.
Should we therefore wait until all light to be made on the
echanisms involved in IPC and rIPC beneficial effects and on
ventual ischemic preconditioning drawbacks? As suggested by
enting et al, a way to overcome such potential limitations might
e combination use of both early and late windows of protection.
ombined ischemic conditioning and pharmacologic approaches
ight also be useful to optimize conditioning protocols.
In the clinical setting, Ali et al5 proved in a randomized
ontrolled trial that rIPC reduced myocardial and renal injury after
bdominal aortic cross-clamping for elective abdominal aortic
neurysm repair. Despite comorbidities, preconditioned patients
resented with better outcomes than not conditioned patients.
Acknowledging that experimental data are still needed and
hat, based on current evidence from small pilot trials, there are too
ew data to be able to say whether IPC has consistent beneficial
ffects,6 we nevertheless believe that implementation of personal-
zed IPC protocols should not be delayed into clinical practice.
arge scale controlled studies should be performed to determine
hether IPC will protect patients during their hospital stay, there-
ore improving their surgical overall outcomes.
iad Mansour, MD, PhD
ichel Kindo, MD, PhD
ulien Pottecher, MD
nne-Laure Charles, PhD
offrey Zoll, PhD
ernard Geny, MD, PhD
ouvel Hopital Civil
trasbourg, France
EFERENCES
. Mansour Z, Bouitbir J, Charles AL, Talha S, Kindo M, Pottecher J, et al.
Remote and local ischemic preconditioning equivalently protects rat
skeletal muscle mitochondrial function during experimental aortic cross-
clamping. J Vasc Surg 2012;55:497-505.
